Table 2.
Preferred follow up duration for the proposed statin interventional trial
| follow up duration | overall - % | uk - % | anz - % | p* |
|---|---|---|---|---|
| 1-7 days |
1.9 |
1.4 |
3.2 |
0.585 |
| 8-14 days |
3.4 |
4.1 |
1.6 |
0.677 |
| 15-21 days |
2.4 |
2.8 |
1.6 |
1.000 |
| 21-28 days |
33.3 |
37.9 |
22.6 |
0.032 |
| 3 months |
29.0 |
22.8 |
43.6 |
0.003 |
| 6 months |
26.1 |
28.3 |
21.0 |
0.304 |
| other |
3.9 |
2.8 |
6.5 |
0.244 |
| total | 100 | 100 | 100 |
Shows respondents’ preferred follow up duration for the proposed statin interventional trial. Data are presented as proportions. * p value for comparison of United Kingdom versus Australia and p = 0.024 when comparing the overall frequency distribution of the responses for ANZ and UK.